Presentations Overview News Events & Presentations Events Presentations Publications Financials & Filings SEC Filings Stock Information Analyst Coverage Stock Quote & Chart Governance Management Team Board of Directors Committee Composition Documents & Charters IR Resources FAQ Email Alerts Contact IR Company Presentations Tourmaline Corporate Overview - January 2025 2.3 MB Tourmaline Investor Day - December 2024 7.1 MB Understanding the Genetic Validation for IL-6 Inhibition in Cardiovascular Disease - November 2024 3.4 MB
Company Presentations Tourmaline Corporate Overview - January 2025 2.3 MB Tourmaline Investor Day - December 2024 7.1 MB Understanding the Genetic Validation for IL-6 Inhibition in Cardiovascular Disease - November 2024 3.4 MB
Understanding the Genetic Validation for IL-6 Inhibition in Cardiovascular Disease - November 2024 3.4 MB
Understanding the Genetic Validation for IL-6 Inhibition in Cardiovascular Disease - November 2024 3.4 MB
